SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Dodgy Ticker who wrote (3094)5/22/1999 8:42:00 PM
From: shero  Read Replies (2) of 3702
 
There is alot here that is baffling. Strum may be the 10 month man but he is not the GBM patient who has survived 39 weeks. I guess there are two 10 month men (and hope for all the girls looking for one-*L*)

There is now a diverse field of knowledge surrounding TNT. There is data from China. There is data from Mexico--which may be where the "Strum" report derives its data--this makes sense because the Mexico TNT study was not conducted by TCLN, but by, I think USC. Now there is both Phase 1 data on TNT for GBM and there was another study done with TNT years ago for prostate cancer, I believe by PAACT, here in the USA. So much data, so little publicity.

Anyone have thoughts about all this?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News